Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.

Recent work suggests that between 50 and 75% of small-cell lung cancer (SCLC) tumours have specific high-affinity binding sites for somatostatin. This study evaluated the potential role of the radiolabelled somatostatin analogue, [111In]pentetreotide, in the detection and staging of SCLC in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Byrne, K. J., Ennis, J. T., Freyne, P. J., Clancy, L. J., Prichard, J. S., Carney, D. N.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968808/
https://www.ncbi.nlm.nih.gov/pubmed/7908220

Ejemplares similares

Ejemplares similares